Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ARTS-II Data Will Drive Multi-Vessel Stenting Payment Push – Cordis

This article was originally published in The Gray Sheet

Executive Summary

Results from the ARTS-II trial comparing drug-eluting stents with bypass surgery will support stent makers' efforts to obtain a higher Medicare payment rate for stenting patients with multi-vessel coronary disease, according to Johnson & Johnson/Cordis
Advertisement

Related Content

Medicare DES Rates Sustained; CMS Cites Paltry Data To Back DRG Change
Medicare DES Rates Sustained; CMS Cites Paltry Data To Back DRG Change
Advertisement
UsernamePublicRestriction

Register

MT021753

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel